UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
Scientists have discovered that cells can sense far beyond the surfaces they touch. While individual cancer cells can probe about 10 microns ahead by tugging on surrounding collagen fibers, clusters ...
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could help the body fight back. The study, published July 2 as the cover story in ...
1 Department of Pathobiology and Biomedical Methodologies, Immunohaemathology and Transfusion Medicine Unit, University Hospital, University of Palermo, Italy 2 Department of Pathobiology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results